MARSI: metabolite analogues for rational strain improvement

Summary Metabolite analogues (MAs) mimic the structure of native metabolites, can competitively inhibit their utilization in enzymatic reactions, and are commonly used as selection tools for isolating desirable mutants of industrial microorganisms. Genome‐scale metabolic models representing all biochemical reactions in an organism can be used to predict effects of MAs on cellular phenotypes. Here, we present the metabolite analogues for rational strain improvement (MARSI) framework. MARSI provides a rational approach to strain improvement by searching for metabolites as targets instead of genes or reactions. The designs found by MARSI can be implemented by supplying MAs in the culture media, enabling metabolic rewiring without the use of recombinant DNA technologies that cannot always be used due to regulations. To facilitate experimental implementation, MARSI provides tools to identify candidate MAs to a target metabolite from a database of known drugs and analogues. Availability and implementation The code is freely available at https://github.com/biosustain/marsi under the Apache License V2. MARSI is implemented in Python.

[1]  Adam M. Feist,et al.  Basic and applied uses of genome-scale metabolic network reconstructions of Escherichia coli , 2013, Molecular systems biology.

[2]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[3]  Jens Nielsen,et al.  Evolutionary programming as a platform for in silico metabolic engineering , 2005, BMC Bioinformatics.

[4]  Eric Johansen,et al.  Enhancing the Sweetness of Yoghurt through Metabolic Remodeling of Carbohydrate Metabolism in Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus , 2016, Applied and Environmental Microbiology.

[5]  Noel M. O'Boyle,et al.  De novo design of molecular wires with optimal properties for solar energy conversion , 2011, J. Cheminformatics.

[6]  J. Nielsen,et al.  Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling , 2014, Molecular systems biology.

[7]  S. Lee,et al.  Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery , 2011, Molecular systems biology.

[8]  Markus J. Herrgård,et al.  Systems biology solutions for biochemical production challenges. , 2017, Current opinion in biotechnology.

[9]  P. Derkx,et al.  The art of strain improvement of industrial lactic acid bacteria without the use of recombinant DNA technology , 2014, Microbial Cell Factories.

[10]  Adam M. Feist,et al.  A comprehensive genome-scale reconstruction of Escherichia coli metabolism—2011 , 2011, Molecular systems biology.

[11]  S. Klamt,et al.  Model-based metabolic engineering enables high yield itaconic acid production by Escherichia coli. , 2016, Metabolic engineering.